Abstract:Abstract Background Rapid, reagent-free pathogen-agnostic diagnostics that can be performed at the point of need are vital for preparedness against future outbreaks. Yet, many current strategies (polymerase chain reaction, lateral flow immunoassays) are pathogen-specific and require reagents; whereas others such as sequencing-based methods; while agnostic, are not (as yet) conducive for use at the point of need. Herein, we present hyperspectral sensing as an opportunity to overcome these barriers, realizing truly agnostic reagent-free diagnostics. This approach can identify both pathogen and host signatures, without complex logistical considerations, in complex clinical samples. The spectral signature of biomolecules across multiple wavelength regimes provides rich biochemical information, which, coupled with machine learning, can facilitate expedited diagnosis of disease states, the feasibility of which is demonstrated here. Innovation First, we present ProSpectral(TM) V1, a novel, miniaturized (~8 lbs) hyperspectral platform with ultra-high (2-5 nm full-width, half-max, i.e., FWHM) spectral resolution that incorporates two mini-spectrometers (visual and near-infrared). This engineering innovation has enabled reagent-free biosensing for the first time. To enable expedient outcomes, we developed state-of-the-art machine learning algorithms for near real-time analysis of multi-wavelength spectral signatures in complex samples. Taken together, these innovations enable near-field ready, reagent-free, expedient agnostic diagnostics in complex clinical samples. Herein, we demonstrate the feasibility of this synergy of ProSpectral(TM) V1 with machine learning to accurately identify SARS-CoV-2 infection status in double-blinded saliva samples in real-time (3 seconds/measurement). The infection status of the samples was validated with the CDC-approved polymerase-chain reaction (PCR). We report accuracies comparable to first-in-class PCR tests. Further, we provide preliminary support that this signal is specific to SARS-CoV-2, and not associated with other respiratory conditions. Interpretation Preparedness against unanticipated pathogens and democratization of diagnostics requires moving away from technologies that demand specific reagents; and relying on intrinsic biochemical properties that can, theoretically, inform on all pathologies. Integration of hyperspectral sensors and in-line machine learning analytics, as reported here, shows the feasibility of such diagnostics. If realized to full potential, the ProSpectral(TM) V1 platform can enable agnostic diagnostics, thereby improving situational awareness and decision-making at the point of need; especially in resource-limited settings - enabling the distribution of newly developed tests for emerging pathogens with only a simple software update. Funding The U.S. Department of Energy, the Defense Threat Reduction Agency, Lawrence Berkeley National Laboratory, Los Alamos National Laboratory, and Pattern Computer Inc.

Rapid and In-situ Detection of Biological Agents via Near-Infrared Spectroscopy and Cloud-Powered Neural Networks

Near Infrared Spectroscopy for Classification of Bacterial Pathogen Strains Based on Spectral Transforms and Machine Learning

Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning

Rapid identification of bloodstream infection pathogens and drug resistance using Raman spectroscopy enhanced by convolutional neural networks

Rapid Discrimination of Clinically Important Pathogens Through Machine Learning Analysis of Surface Enhanced Raman Spectra

Rapid and On-Scene Chemical Identification of Intact Explosives with Portable Near-Infrared Spectroscopy and Multivariate Data Analysis

Classification of Pathogenic Bacteria Using Near-Infrared Diffuse Reflectance Spectroscopy

Stand-off hazardous materials identification based on near-infrared hyperspectral imaging combined with convolutional neural network

Metabolism-triggered sensor array aided by machine learning for rapid identification of pathogens

Enhancing Open-World Bacterial Raman Spectra Identification by Feature Regularization for Improved Resilience against Unknown Classes

Identification of Microbes in Wounds Using Near-Infrared Spectroscopy.

Evaluation of the SERS performances of Tabun and VX label-free detection in complex and multicomponent fluids

Classification of Respiratory Syncytial Virus and Sendai Virus Using Portable Near-infrared Spectroscopy and Chemometrics

FT-IR Hyperspectral Imaging and Artificial Neural Network Analysis for Identification of Pathogenic Bacteria

Detecting Respiratory Viruses Using a Portable NIR Spectrometer—A Preliminary Exploration with a Data Driven Approach

A Dendrimer-Based Platform Integrating Surface-Enhanced Raman Scattering and Class-Incremental Learning for Rapidly Detecting Four Pathogenic Bacteria

Reagent-free Hyperspectral Diagnosis of SARS-CoV-2 Infection in saliva samples

Machine Learning-Assisted Raman Spectroscopy and SERS for Bacterial Pathogen Detection: Clinical, Food Safety, and Environmental Applications

Label-free detection and discrimination of respiratory pathogens based on electrochemical synthesis of biomaterials-mediated plasmonic composites and machine learning analysis

Rapid Identification of Infectious Pathogens at the Single-Cell Level via Combining Hyperspectral Microscopic Images and Deep Learning